Keywords: Elan, EDT, Alkermes, Share sale, Roche, Illumina, FTC, Antitrust

Elan cashes in 76% chunk of its Alkermes stake for $381 million; Roche updates on Illumina bid

Article | 14 March 2012

Print This

Ireland-based Elan Corp (NYSE: ELN) revealed yesterday that it has raised around $381 million in net proceeds from the sale of 76% (24.15 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in